JP2024527940A5 - - Google Patents

Info

Publication number
JP2024527940A5
JP2024527940A5 JP2024504834A JP2024504834A JP2024527940A5 JP 2024527940 A5 JP2024527940 A5 JP 2024527940A5 JP 2024504834 A JP2024504834 A JP 2024504834A JP 2024504834 A JP2024504834 A JP 2024504834A JP 2024527940 A5 JP2024527940 A5 JP 2024527940A5
Authority
JP
Japan
Prior art keywords
alkyl
process according
glycero
membered heteroaryl
membered heterocycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024504834A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527940A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038152 external-priority patent/WO2023009422A1/en
Publication of JP2024527940A publication Critical patent/JP2024527940A/ja
Publication of JP2024527940A5 publication Critical patent/JP2024527940A5/ja
Pending legal-status Critical Current

Links

JP2024504834A 2021-07-26 2022-07-25 ペイロード分子を気道上皮に送達するための脂質ナノ粒子組成物を調製するプロセス Pending JP2024527940A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163225822P 2021-07-26 2021-07-26
US63/225,822 2021-07-26
PCT/US2022/038152 WO2023009422A1 (en) 2021-07-26 2022-07-25 Processes for preparing lipid nanoparticle compositions for the delivery of payload molecules to airway epithelium

Publications (2)

Publication Number Publication Date
JP2024527940A JP2024527940A (ja) 2024-07-26
JP2024527940A5 true JP2024527940A5 (cg-RX-API-DMAC7.html) 2025-08-04

Family

ID=82899171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504834A Pending JP2024527940A (ja) 2021-07-26 2022-07-25 ペイロード分子を気道上皮に送達するための脂質ナノ粒子組成物を調製するプロセス

Country Status (6)

Country Link
US (1) US20240366522A1 (cg-RX-API-DMAC7.html)
EP (1) EP4376815A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024527940A (cg-RX-API-DMAC7.html)
CN (1) CN118019526A (cg-RX-API-DMAC7.html)
TW (1) TW202320737A (cg-RX-API-DMAC7.html)
WO (1) WO2023009422A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020002348A (es) 2017-08-31 2020-10-08 Modernatx Inc Métodos de elaboración de nanopartículas lipídicas.
CN113939282A (zh) 2019-01-31 2022-01-14 摩登纳特斯有限公司 制备脂质纳米颗粒的方法
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
EP4429644A1 (en) * 2021-11-12 2024-09-18 ModernaTX, Inc. Compositions for the delivery of payload molecules to airway epithelium
EP4694871A1 (en) * 2023-04-14 2026-02-18 Beijing Jitai Pharmaceutical Technology Co., Ltd. Lipid nanoparticle compositions and uses thereof
AU2024384477A1 (en) 2023-11-21 2026-05-21 Modernatx, Inc. Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
CN120718086B (zh) * 2024-06-13 2026-06-26 仁景(苏州)生物科技有限公司 用于递送的脂质化合物和脂质纳米颗粒
WO2026128816A1 (en) * 2024-12-13 2026-06-18 Massachusetts Institute Of Technology Compositions and methods for stabilizing biomolecules

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681702A (en) 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
EP2857499A1 (en) 2010-10-01 2015-04-08 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US9999673B2 (en) 2011-01-11 2018-06-19 Alnylam Pharmaceuticals, Inc. PEGylated lipids and their use for drug delivery
WO2013103659A1 (en) 2012-01-04 2013-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
WO2014093924A1 (en) 2012-12-13 2014-06-19 Moderna Therapeutics, Inc. Modified nucleic acid molecules and uses thereof
PT2922554T (pt) 2012-11-26 2022-06-28 Modernatx Inc Arn modificado nas porções terminais
WO2014164253A1 (en) 2013-03-09 2014-10-09 Moderna Therapeutics, Inc. Heterologous untranslated regions for mrna
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN105143456A (zh) 2013-03-15 2015-12-09 不列颠哥伦比亚大学 用于转染的脂质纳米粒子和相关方法
DK3386484T3 (da) 2015-12-10 2022-07-04 Modernatx Inc Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
US20180153822A1 (en) * 2016-11-10 2018-06-07 Translate Bio, Inc. Process of Preparing mRNA-Loaded Lipid Nanoparticles
JP7256824B2 (ja) * 2018-04-25 2023-04-12 エスリス ゲーエムベーハー 粒子状製剤用の凍結保護剤
US12076439B2 (en) * 2018-05-24 2024-09-03 Translate Bio, Inc. Thioester cationic lipids
CN113939282A (zh) * 2019-01-31 2022-01-14 摩登纳特斯有限公司 制备脂质纳米颗粒的方法
CA3146369A1 (en) * 2019-07-08 2021-01-14 Translate Bio, Inc. Improved mrna-loaded lipid nanoparticles and processes of making the same

Similar Documents

Publication Publication Date Title
JP2024527939A5 (cg-RX-API-DMAC7.html)
JP2023538260A5 (cg-RX-API-DMAC7.html)
CN118319880B (zh) 靶向肺部高效递送核酸的脂质纳米颗粒、吸入式制剂及应用
JP2025502627A5 (cg-RX-API-DMAC7.html)
US20130037977A1 (en) Preparation of Lipid Nanoparticles
JP2024542099A5 (cg-RX-API-DMAC7.html)
JP2020510072A5 (cg-RX-API-DMAC7.html)
CN119317431A (zh) 使用阳离子胆固醇用于核酸递送的局部递送的脂质纳米颗粒
JP2018532721A5 (cg-RX-API-DMAC7.html)
JP2024545584A5 (cg-RX-API-DMAC7.html)
RU2660585C2 (ru) Фармацевтическая композиция для уменьшения осложнений применения стероидных препаратов при лечении офтальмологических заболеваний
TW200916126A (en) Organic compounds
CN115708818B (zh) 一种用于雾化吸入脂质纳米粒的通用型处方
EP4079298A1 (en) Kit for preparing nanoparticle composition for drug delivery, comprising polylactic acid salt
WO2024046448A1 (en) Lyophilized formulations and liquid formulations of lipid nanoparticles
US8871252B2 (en) pH-responsive liposome
JP6230538B2 (ja) 安定なオキサリプラチン封入リポソーム水分散液及びその安定化方法
JP7832717B2 (ja) 硫化物を含むイオン化可能な脂質、及びこれを含む脂質ナノ粒子
US20230355539A1 (en) Lipid-polymer compositions and methods of use
CN117946201A (zh) 脂质化合物和脂质纳米颗粒组合物
US8241663B2 (en) Liposome preparation
WO2023183297A1 (en) Ion channel prosthetic compositions comprising lipid-coated crystals of amphotericin b
KR102772764B1 (ko) 트레할로즈 유도체 및 신규 구조 유지 화합물을 포함하는 핵산 의약품 전달용 지질나노입자의 약학 조성물
WO2025012723A1 (en) Liposome encapsulated apomorphine
CN106619509B (zh) 一种奥沙利铂和伊立替康共载载药脂肪乳及其制备方法